Class I and IVa β-tubulin isotypes expressed in adult mouse brain are glutamylated  by Mary, Jean et al.
FEBS Letters 353 (1994) 89-94 
FEBS 14631 
Class I and IVa /3-tubulin isotypes expressed in adult mouse brain are 
glutamylated 
Jean Mary”, Virginie Redekef, Jean-Pierre Le Caer”, Jean-Claude Promkb, Jean Rossiera’* 
“Institut AIfred Fessard, CNRS UPR 2212, 91198 Gif-sur- Yvette Cedex, France 
bLaboratoire de Pharmacologic et Toxicologic Fondamentales, CNRS VPR 8221, 31077 Toulouse Cedex, France 
Received 25 August 1994 
Abstract Several types of post-translational modifications contribute to the high level of tubulin heterogeneity in the brain. An important 
modification is glutamylation of the major brain-specitic isotypes, such as class Is/b of a-tubulin and classes II and III ofgtubulin. Here we describe 
experiments to determine if additional, minor tubulin isotypes, expressed in adult mouse brain, could also be glutamylated. Purified tubulin from 
adult mouse brain was cleaved with thennolysin. Proteolytically released carboxy-terminal peptides of both a- and p-tubulin were isolated by 
sequential anion exchange and reverse-phase column-chromatography. Anionic peptides were then characterized by amino acid sequencing and mass 
spectrometry. We show that brain-specific lass IVa and constitutive class I /I-tubulin isotypes can be glutamylated, at GAUGE and GluU’, respectively. 
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1. Introduction boxy-terminal sequence could modulate the interaction with 
Ca”, an inhibitor of tubulin assembly [26]. 
Brain tubulin exhibits a high degree of heterogeneity up to 
21 isoforms having been resolved by IEF [l]. This heterogeneity 
is due both to differential expression of a- arid/3--tubulin genes, 
producing 5 a- and 6 jI-tub&n isotypes in mammals [2,3], and 
to subsequent post-translational modifications of these isogene 
products (for review see [4]). For a-tubulin, the following post- 
translational modifications have been described: reversible ace- 
tylation of Lys“” [5], removal and re-addition of the C-terminus 
Typ” [6], removal of the G1u4” after detyrosylation [7l, and 
polyglutamylation of Glu”’ [8]. For /I-tubulin, it has been re- 
ported that the neuron-specific class III isotype can be 
phosphorylated at Se?“’ [9,10] or Tyfias7 [l 11, and polyglutam- 
ylated at G1u438 [12]. The brain-specific class II isotype can also 
be glutamylated at GAUGE’ [13,14]. 
The aim of this work was to determine if minor /I-tubulin 
isotypes expressed in adult mouse brain could also be modified 
by post-translational polyglutamylation. Previous studies have 
reported that digestion of mouse brain tubulin dimers by ther- 
molysin releases the peptide 440VEGEGEEEGEEY4” from the 
carboxy-terminus of isotypes ma1/2 [8,27]. In the present paper 
we show that this treatment also releases carboxy-terminal pep- 
tides of other tubulin isotypes expressed in adult mouse brain. 
These peptides were characterized both by sequence analysis 
and mass spectrometry. We demonstrated that the brain spe- 
cific class IVaj?-tubulin isotype (gene n$4) and the constitutive 
class I /I-tubulin isotype (gene m,85) can be glutamylated at 
G1u434 and Glu”‘, respectively. 
With the exception of acetylation, these different post-trans- 
lational modifications occur in the carboxy-terminal domain of 
both a- and/?-tubulins, and more precisely in the hypervariable 
region [15], which extends, for a-tubulins from residue 440 to 
451, and for p-tubulins from 43 1 to 445. Most of the heteroge- 
neity between the different isotypes is localized in these regions 
[ 161 which are rich in acidic amino acid residues. Thus glutam- 
ylation increases the acidity of an already highly acidic domain 
of tubulins. Futhermore, this negatively-charged carboxy-ter- 
minal tail of the molecules is exposed at the outer surface of the 
microtubule, and is known to be functionally important. It is 
involved in the interaction with various MAPS including struc- 
tural [17-191 and motor proteins [20-221. Such interactions 
could regulate both the dynamics of tubulin assembly into 
microtubules and microtubule-mediated transport of various 
cellular components [20,23-251. Furthermore, this acidic car- 
2. Materials and methods 
2. I. Chemicals 
The following were purchased: 1 ,4-piperazine diethanesulfonic acid 
(Pipes) and guanosine S&phosphate (GTP) (Boehringer-Mrnmheim); 
Tris (hydroxymethyl)-aminomethan (Merck); Ethylene glycol bis (s- 
aminoethyl ether)-N,N,N’,N’-tetra cetic acid (EGTA) (Sigma); Ace- 
tonitrile (Baker) and trifluoroacetic acid (TFA) (Applied Biosystem). 
Tax01 purified from Taxus baccata was a gift from Dr. D. Guenard 
(ICSN, Gif-sur-Yvette, France). 
2.2. T&din purification 
Tubulin was prepared from adult mice (Swiss-IFFA CREDO) brains 
by taxol-induced microtubule assembly, according to Vallee et al. [28]. 
To determine the concentration of tubulin the method of Bradford was 
used [29]. 
2.3. Proteolytic digestion 
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Abbreviations: DEAE, diethylaminoethyl; IEF, isoelectro focusing; 
HPLC, high-performance liquid chromatography; L-SIMS, liquid sec- 
ond ion mass spectrometry; MAPS, microtubule associated proteins; 
SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophore- 
sis; TFA, trifluoroacetic acid. 
Tubulin f2 ma/ml in 0.1 mM Pines. 2 mM EGTA. 1 mM M&l,. oH 
6.8) was digested with thermolysid (Bbehringer Mannheim), inUtheio- 
lysin-buffer (50 mM Tris-HCl buffer, pH 8, containing 0.1 mM CaClJ 
with 1: 20 enzyme/substrate (w/w), for 5 h at 37’C. The reaction was 
stopped by freezing the sample at -80°C. Before injection on the HPLC 
column, the thermolysin digestion products were centrifuged at 
12,000 x g for 2 min. 
2.4. HPLC separation 
Purification of the carboxy-terminal acidic peptides of a- and p- 
tubulin was performed by anion exchange chromatography followed by 
0014-5793/94/%7.00 Q 1994 Federation of European Biochemical Societies. All rights reserved 
SSDZ 0014-5793(94)01018-8 
90 
reverse-phase chromatography on a Waters (Millipore) HPLC appara- 
tus. The elution was monitored at 214 nm. 
The DEAE column (DEAE 5PW, Protein Pack, 75 x 7.5 mm, Wa- 
ters) was eluted with a linear gradient from 0 to 100% of buffer B in 
60 min at a flow rate of 1 ml/min. Buffer A was 20 mM Tris-HCl, pH 
8.0,50 mM NaCl, and buffer B was 20 mM Tris-HCl, pH 8.0,500 mM 
NaCl. The fractions eluted from the DEAE column were further puri- 
fied by reverse-phase HPLC. 
The reverse-phase column (C-l 8,5 pm, Brownlee, 220 x 2.1 mm) was 
eluted at 15’C at a flow rate of 200 @min. Solvent C was deionized 
water and solvent D was 80% acetonitrile in water. These two solvents 
were acidified to pH 3 with trifluoroacetic acid. The fractions collected 
from the DEAE column were eluted with a step-gradient of solvent D 
(80% v/v a&o&rile, pH 3) as follows: 1% D in C for 10 min, then from 
1 to 10% for 1 min, and finally from 10 to 45% in 35 min. Before 
injection, the pH of each sample was adjusted to pH 3.0 with TFA. 
2.5. Amino acid sequencing 
Peptides were sequenced by automated Edmau degradation using a 
470A gas-liquid sequenator (Applied Biosystems) with the modification 
described by Le Caer and Rossier [30]. 
2.6. Mass spectrometry 
L-SIMS analysis was carried out on an Autospec 6F mass spectrom- 
eter (Fison, Manchester, UK). Spectra were generated by a 25 keV 
cesium ion beam. Cesium iodide clusters were used for mass calibration. 
The sample matrix was a 1: 1 mixture of glycerol and thioglycerol. The 
spectra resulted from averaging ten scans/spectra with a resolution of 
2000. Methylation of free carboxylic groups was performed as de- 
scribed by Redeker et al. [271 except hat about 2&100 pmol of peptide 
was used in each experiment. 1~1 of this solution was mixed with 1~1 
of the matrix directly on the target and analyzed immediately. 
3. Results 
3.1. Digestion of purified brain tubulins, and separation of 
carboxy- terminal peptides 
After purification by taxol-induced microtubule assembly, 
brain tubulin was digested by thermolysin. The completion of 
the enzymatic digestion was verified by SDS-PAGE analysis 
(results not shown). Since the cleavage-specificity of thermoly- 
sin is broad [31], a large number of peptides were generated by 
hydrolysis with this enzyme. To isolate the acidic carboxy- 
terminal fragments of tubulins, peptide products were sepa- 
rated on a DEAE column (Fig. 1). Previous studies have re- 
ported that, under these conditions, the acidic carboxy-terminal 
peptides of both a- and j?-tubulin were eluted after 25 min and 
that peaks DEAE-0 to -3 contained peptides of isotypes ma112 
unmodified, mono, bi and triglutamylated, respectively [8,27]. 
Peaks DEAE-0 to -7 were collected as separate fractions and 
further purified by reverse-phase HPLC. Individual carboxy- 
terminal peptides were subsequently characterized by sequence 
analysis and mass spectrometry. The results of the identifica- 
tion of the different peptides eluted in fractions DEAE-0 to 
DEAE-7 are presented in Table 1. 
3.2. Glutamylation of the constitutive class I /Ltubulin isotype 
The reverse-phase elution profile of peak DEAE-0 is shown 
in Fig. 2, panel A. Three peaks were resolved and denoted 
as RP-1 to RP-3. The amino acid sequence obtained for the 
peptide eluted under peak RP-3 was FGEEAXEE---. This 
sequence matches the carboxy-terminal sequence of class I 
j?-tubulin isotype (gene m/95), from residues 436 to 443, 
where X indicates that no signal corresponding to G1uU’ was 
detected. It has been reported previously that such a gap in the 
sequence of carboxy-terminal tubulin peptides could be the 
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result of glutamylation of the y-carboxylic group of a glutamyl 
residue [8]. To confirm the nature of the modification and to 
determine the number of glutamyl units post-translationally 
added to Glu”‘~ the mass of the peptide was measured by 
L-SIMS (Fig. 3, panel B). The ion at mass/charge ratio (m/z) 
1237.2 corresponds to the carboxymethylated peptide 
436FGEEAEEEA“““, with an additional mass of 143 Da, which 
is the mass of a carboxymethylated glutamyl unit. Thus it is 
proposed that the corresponding peptide is monoglutamylated. 
No higher degrees of glutamylation for this class I /I-tubulin 
isotype at position G1ua’ have been found in the other DEAE 
peaks. This suggests that higher degrees of glutamylation of this 
class of tubulin do not exist at a detecTable level, in our condi- 
tions, in the murine brain. 
Fractions RP-1 and -2 (Fig. 2, panel A) contained carboxy- 
terminal peptides of ma112 tubulin isotypes, starting at amino 
acid 440 (Table 1). The peptide eluted under peak RP-1 ex- 
tended to amino acid 449 and bore a glutamyl residue added 
post-translationally on G1uM5, whereas the peptide eluted under 
peak RP-2 extended to amino acid 450 and was unmodified 
[7,32]. Both of these peptides had the same mass, the mass- 
spectrum of the carboxymethylated peptide eluted as peak RP- 
2 being shown in Fig. 3, panel A. Thus, these two peptides 
differed by the position of a single glutamyl residue. 
3.3, Glutamylation of the brain-specific class IVa /Uubulin 
isotype 
The reverse-phase lution profile of fraction DEAE-4 is 
A 
RETENTION TIME (min.) 
Fig. 1. Purification by DEAE HPLC of the tubulin carboxy-terminal 
peptides obtained after thermolysin treatment. The complete elution 
profile from cleaved tubulins is shown in panel A, and the boxed region 
is shown enlarged in panel B. Fractions, denoted DEAE-0 to DEAE-7, 
were collected separately for further purification. 
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Fig. 2. Reverse-phase HPLC purification of the fractions of tubulin 
fragments collected from the DEAE column. The elution profile of 
fractions DEAE-0 and DEAE-4 are shown in panels A and B, respec- 
tively. Fractions were denoted RP-1 to RP-6. The peak denoted by * 
results of the rapid increase of the solvent B concentration at the 
beginning of the gradient. 
shown in Fig. 2, panel B. Three peaks were resolved and de- 
noted RP-4 to RP-6. Fractions RP-5 and RP-6 each contained 
a peptide with the sequence AEEGXFEEEA---, which matches 
the carboxy-terminal sequence of class IVa /I-tubulin (isotype 
n$4), from residues 430 to 439. No signal was detected for the 
cycle corresponding to G1u4%. As it was assumed, this position 
is probably modified by addition of one or more glutamyl unit. 
By mass spectrometry, the same molecular mass for these two 
peptides was obtained. The mass spectrum of the peptide eluted 
as fraction RP-5 is shown in Fig. 3, panel D. The ion at m/z 
ratio 1952.5 corresponds to the carboxymethylated peptide 
430AEEGEFEEEAEEE”Z, with addition of two units of 143 
Da. Thus, the peptide appeared to be biglutamylated. This 
result shows that class IVa B-tubulin isotype can be glutam- 
ylated, and that the two peptides eluted as fractions RP-5 and 
RP-6 have been post-translationally modified by the addition 
of two glutamyl residues. 
The two peptides could differ by the linkage between the two 
glutamyl groups added post-translationally on to G1u434. The 
second additional glutamyl unit can be linked by an amide bond 
from either the a- or the y-carboxyl group of the first glutamyl 
unit added. However, the existence of two sites of glutamyla- 
tion, GAUGE and GLUM, each modified by the addition of one 
glutamyl unit cannot be excluded since the last three residues 
(from G1uw to G1t.1~~) could not be obtained by sequencing. 
According to this latter hypothesis, one of the fractions, RP-5 
or RP-6, could contain a peptide biglutamylated at G1u434 and 
the other peak a peptide modified at both positions, G1u434 and 
Glum, each by one glutamyl unit. 
Carboxy-terminal peptides of class IVa /I-tubulin were also 
identified in fractions DEAE-2, -3, -5 and -6 bearing no, one, 
thme and four additional glutamyl units respectively (see Table 1). 
The peptide eluted as fraction RP-4 matched the carboxyl 
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terminus of the class II B-tubulin isotype, from amino acids 430 
to 443, bearing two glutamyl units added post-translationally 
(mass spectrum shown in Fig. 3, panel C). This confirms results 
reported previously for polyglutamylation of class II /Ltubulin 
isotypes [13,14]. 
4. Discussion 
In this study, the different tubulin isotypes expressed in adult 
mouse brain, with the exception of class III /I-tubulin, were 
isolated. Glutamylation of the major brain-specific tubulin 
isotypes previously described was observed, and we have in 
addition characterized glutamylation of class I and IVa /I-tu- 
bulin isotypes. We have shown that the brain-specific j?-tubulin 
isotype class IVa (gene n@4) and the constitutive /I-tubulin 
isotype class I (gene rr$S) can be glutamylated, at GAUGE and 
Gl@’ respectively. Expression levels of these two /I-tubulin 
isotypes in mouse brain are minor compared to those of class 
II and III /I-tubulin isotypes (see Table l), [33,34]. Thus glutam- 
ylation, even of these minor /3-tubulin isotypes, contributes a 
major part, over the other reported post-translational modifica- 
tions, to the high heterogeneity of brain tubulins [8]. Recently, 
immunoblotting studies using a monoclonal antibody (GT335) 
recognizing glutamylated tubulin [35,36] have suggested that 
the high heterogeneity of axonemal tubulin from mammalian 
spermatozoa is partially correlated with post-translational 
polyglutamylation. It was proposed that the major testis-spe- 








Fig. 3. Mass spectrometry analysis of carboxymethylated tubulin car- 
boxy-terminal peptides. Monoisotopic m/z values of the protonated 
molecular ions (MH’) are indicated. Spectra of carboxymethylated 
carboxy-terminal peptides: unmodified m&1/2 isotype (fraction RP-2), 
m#?S bearing one additional glutamyl unit (RP-3), and n$2 (RP-4) and 
n@I (RP-5), each bearing two additional glutamyl units, are shown in 
panels A, B, C and D, respectively. 
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Table 1 
Sequence and mass (MH’) obtained for the different peptides contained in fractions DEAE-0 to -7 
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DEAE sequence MSSS 
peaks MH+ the m&cUld 
VEGEGEEEGE 
VEGEGXJZEG- 1304.5 ma1/2 (44o.449) 53 
AEEGXFEEEA- 
VEGEGEEEGEEY 
4’ VEGEGXEZEG-- 1753.4 
&)2 ma1/2 (44U51) loo 
ADEQGXFEEEEG- 2252.5 
ADEQGEFEEEEGEDEA 
&I* mp2 (430-145) 
75.8 
‘4 I ] 
~AEEGEFEEEAEEE 
I [ 
AEEGXFEEEA-- ! AEEGEFEEEAEEE j mw (430-142) 
I I iW3 rng4 (43O-l42) 22.2 AEEGXFEEEA- 2095.5 or (with m+n=3) AEEGEFEEEAEEE 








&)4 ma1/2 (44l!-451) l3 
AEEGEFEEEAEEE 
AEEGXFEEEA- 2238.4 &)4 12.9 
OT (with otp=4) rnv (430-142) 
AEEGEFEEEAEEE 
I ! 
I I (‘E)o (Eh I 
7 ADEQGXFEEEEG-- 2681.5 
ADEQGEFEEEEGEDEA 
(&s 
mg2 (430-145) loo 
Localisation in the molecule refers to the sequences of tubulin isotypes published by Sullivan [38]. The relative amount (%) of each carboxy-terminal 
tubulin peptide was calculated by dividing by the total amount of peptide eluted in each DEAE fraction. 
tubulin isotypes are glutamylated. Our results indicate that the 
constitutive isotype class I can be polyglutamylated in adult 
mouse brain, and we have specified the site where this modifi- 
cation occurs. 
Since the original discovery of glutamylation of ma112 tu- 
bulin isotypes at G~u““~ [8], several other isotypes have been 
found to be glutamylated. Alexander et al. [12] have shown that 
the neuron-specific lass III /I-tubulin isotype from adult bo- 
vine brain can be polyglutamylated at G~u~~*. Redeker et al. [ 131 
and Rtidiger et al. [14] have reported that the major neuron- 
specific class II /I-tubulin isotype from pig brain can be polyglu- 
tamylated at GAUGE’. Together with our present observations, it 
thus appears that all fi-tubulin isotypes expressed in mouse 
brain can be glutamylated. 
In Table 2 the primary sequences of the glutamylated car- 
boxy-terminal tubulin peptides described to date have been 
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Table 2 
Comparison of the carboxy-terminal sequences of the different a- and /3-tubulin isotypes known to be glutamylated 
10 +2 
mall2 438vDSvEGFGEEF,GEEY 
ml32 class11 427DATADEQGEF& EEEGEDEA 
mp3 classIVb 42 7 D A T A E E EmEEAEEEVA 
m/34 classIVa 426QDATAEFGEFEEEAEEEVA 
or 
432EGEF~EEAEEEV_q 
mp5 class1 433EE DFGEEAEEEA 
b/32 class111 430AEEJGEMYEDDEESEAQGPK 
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m: mouse, b: bovine. Experimentally verified, modified glutamyl residues are shown in bold letters. A pentapeptide homologous between all of the 
sequences i  underlined. 
aligned at their respective modified glutamyl residue. In the 
a-tubulin (ma1/2), class II (m/32) and IVa (mjI4) /3-tubulin the 
modified residues are sequentially equivalent to one another, 
as shown by the homologous pentapeptides (underlined) that 
each contain the modified residue. Using this homology we can 
predict, for example that GAUGE’ of the closely-related class IVb 
/I-tubulin (m/33) is likely glutamylated. However, in the class I 
j?-tubulin (r435) the equivalent residue at a first site (under- 
lined) is not glutamyl, but Asp435 (Table 2) and another glu- 
tamyl residue, at a second site further along the sequence 
(Glu”‘) is found to be modified. By homology with this latter 
experimentally identified site, G1t.1~ in the class IVa /I-tubulin 
may be expected to be modified, in addition to Glu4”. Further- 
more, in the class III /Stubulin (bjI2) (Table 2) G~u~‘~ is not 
modified, whereas the subsequent glutamate in the sequence 
(GAUGE’) is as reported by Alexander et al. [12]. Overall this 
represents a complicated situation which renders analysis and 
prediction of the site(s) of glutamylation difficult. For now, it 
would seem that the enzyme or enzymes responsible for glutam- 
ylation recognise locally similar, rather than globally homolo- 
gous subtrates. Nevertheless, in each case it appears that the 
enzyme is able to specifically recognize a particular glutamyl 
residue. Thus, from the alignment of experimental positions 
shown in Table 2, relative to the modified glutamyl (position 
0) residues at position -1 are hydrophobic and usually Ala or 
Gly, and are acidic (Glu or Asp) at position +2. Clearly how- 
ever, these restrictions are insufficient by themselves to deter- 
mine substrate-specificity. 
Glutamylation modifies the carboxy-terminal region of tu- 
bulin, which is implicated in interactions between microtubules 
and MAPS. Kotani et al. [37] have suggested that binding of 
MAPS to microtubules is based upon electrostatic as well as 
hydrophobic interactions. Thus by increasing the negative 
charge in this region, polyglutamylation could modulate affin- 
ity of MAPS for the carboxy-terminal region of tubulin 
isotypes, and thereby influence the stability of the microtubule. 
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